ibs and tirzepatide What are the considerations for using (a dual GIP (glucose-dependent insulinotropic polypeptide) GLP-1 (glucagon-like peptide-1) receptor agonist) in patients with pre-existing gastrointestinal conditions, such as gastroparesis Tirzepatide and pH Balance: The

Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide

Power analysis was performed with Cohen's effect size = 0.8, significance = 0.05, sample sizes required for all experiments were satisfied

Disruption of dopamine homeostasis associated with alteration of proteins in synaptic vesicles: A putative central mechanism of Parkinsons disease pathogenesis

In the SELECT trial, semaglutide reduced the incidence of major adverse cardiovascular events, including heart attack and stroke, by 20% in individuals with established cardiovascular disease and obesity but without diabetes [10]

It is not known if semaglutide will cause thyroid tumors or MTC in people